A randomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesothelioma - 'RESPECT-Meso'

QR Code

A randomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesothelioma - 'RESPECT-Meso'

Background: Malignant pleural mesothelioma (MPM) is a cancer with a high symptom burden and a median survival of less than one year. Evidence from other cancer types suggests there may be some benefit in health related quality of life (HRQoL) with the integration of early specialist palliative care...

Full description

Bibliographic Details
Main Authors:	Brims, Fraser, Gunatilake, S., Lawrie, I., Marshall, L., Fogg, C., Qi, C., Maskell, N., Forbes, K., Rahman, N., Morris, S., Gerry, S., Chauhan, A.
Format:	Conference Paper
Language:	English
Published:	2018
Subjects:	Science & Technology Life Sciences & Biomedicine Oncology
Online Access:	http://hdl.handle.net/20.500.11937/75022

Similar Items

RESPECT-MESO: AN INTERNATIONAL MULTICENTRE NON-BLINDED RANDOMIZED CONTROLLED TRIAL TO ASSESS THE IMPACT OF REGULAR EARLY SPECIALIST PALLIATIVE CARE IN MALIGNANT PLEURAL MESOTHELIOMA
by: Brims, Fraser, et al.
Published: (2017)

A multicentre non-blinded randomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesothelioma (RESPECT-MESO): Study protocol for a randomised controlled trial
by: Gunatilake, S., et al.
Published: (2014)

Early specialist palliative care on quality of life for malignant pleural mesothelioma: A randomised controlled trial
by: Brims, Fraser, et al.
Published: (2019)

Prognostic factors for malignant pleural mesothelioma
by: Brims, Fraser, et al.
Published: (2013)

Epidemiology of Malignant Pleural Mesothelioma in Australia
by: De Klerk, N., et al.
Published: (2016)

Postmortem findings of malignant pleural mesothelioma: A two-center study of 318 patients
by: Finn, R., et al.
Published: (2012)

Asbestos Related non-Malignant Pleural Disease and Mesothelioma
by: Musk, B., et al.
Published: (2016)

Asbestos exposure and histological subtype of malignant mesothelioma
by: Franklin, P., et al.
Published: (2016)

Predicting survival in malignant mesothelioma
by: Musk, A., et al.
Published: (2011)

Incidence of malignant mesothelioma in Aboriginal people in Western Australia.
by: Franklin, P., et al.
Published: (2016)

Wnt Signalling in Malignant Mesothelioma
by: Richards, Alexander S.K.
Published: (2016)

Risk factors for malignant mesothelioma in people with no known exposure to asbestos
by: Musk, B., et al.
Published: (2017)

A novel clinical prediction model for prognosis in malignant pleural mesothelioma using decision tree analysis
by: Brims, Fraser, et al.
Published: (2016)

Serum mesothelin for early detection of asbestos-induced cancer malignant mesothelioma
by: Creaney, J., et al.
Published: (2010)

Comparison of outcomes following a cytological or histological diagnosis of malignant mesothelioma
by: Muruganandan, S., et al.
Published: (2017)

Validation of an Asbestos Job-Exposure Matrix: Exposure-Response Relationships for Malignant Mesothelioma
by: Kamiya, H., et al.
Published: (2018)

Absence of germline mutations in BAP1 in sporadic cases of malignant mesothelioma
by: Sneddon, S., et al.
Published: (2015)

A genome-wide association study for malignant mesothelioma risk
by: Cadby, G., et al.
Published: (2013)

Pattern of malignant mesothelioma incidence and occupational exposure to asbestos in Western Australia.
by: Musk, A., et al.
Published: (2015)

ROUTINELY COLLECTED CLINICAL AND LABORATORY DATA CAN RELIABLY PREDICT LONGER SURVIVAL IN MALIGNANT PLEURAL MESOTHELIOMA
by: Brims, Fraser, et al.
Published: (2014)

Routinely Collected Clinical And Laboratory Data Can Reliably Predict Longer Survival In Malignant Pleural Mesothelioma
by: Brims, Fraser, et al.
Published: (2014)

Familial aggregation of malignant mesothelioma in former workers and residents of Wittenoom, Western Australia
by: De Klerk, N., et al.
Published: (2013)

Palliative care in mesothelioma
by: Brims, Fraser
Published: (2018)

Prediction modelling using routine clinical parameters to stratify survival in Malignant Pleural Mesothelioma patients undergoing cytoreductive surgery.
by: Harris, E., et al.
Published: (2018)

Increasing incidence of malignant mesothelioma after exposure to asbestos during home maintenance and renovation
by: Olsen, N., et al.
Published: (2011)

MESOTHELIOMA IN AUSTRALIA-RESULTS FROM THE AUSTRALIAN MESOTHELIOMA REGISTRY
by: Sim, M., et al.
Published: (2016)

Mesothelioma in australia: A review
by: Musk, A., et al.
Published: (2017)

Expression profile and function of Wnt signaling mechanisms in malignant mesothelioma cells
by: Fox, Simon, et al.
Published: (2013)

Induction of apoptosis in murine malignant mesothelioma cell lines: gene expression and susceptibility
by: Kusmiaty
Published: (2003)

Characterisation of genes derived from murine malignant mesothelioma by suppression subtractive hybridization
by: Thean, Ai Lee
Published: (2002)

Body composition and nutritional status in malignant pleural mesothelioma: implications for activity levels and quality of life.
by: Jeffery, E., et al.
Published: (2019)

Predicted mortality from malignant mesothelioma among women exposed to blue asbestos at Wittenoom, Western Australia
by: Reid, Alison, et al.
Published: (2009)

SURVIVAL IN MESOTHELIOMA: AN ANALYSIS OF DIFFERENT DIAGNOSTIC TECHNIQUES
by: Muruganandan, S., et al.
Published: (2016)

Malignant mesotheliomas in former miners and millers of crocidolite at Wittenoom (Western Australia) after more than 50 years follow-up
by: Berry, G., et al.
Published: (2012)

Regularity and directional differentiability with respect to parameters of solutions to nonlinear switching systems
by: Ye, J., et al.
Published: (2015)

The continual search for ideal biomarkers for mesothelioma: The hurdles
by: Brims, Fraser, et al.
Published: (2013)

Effect of NSAIDS and COX-2 inhibitors on the incidence and severity of asbestos-induced malignant mesothelioma: Evidence from an animal model and a human cohort
by: Robinson, C., et al.
Published: (2014)

Mechanisms of cisplatin-induced cell death in malignant mesothelioma cells: Role of inhibitor of apoptosis proteins (IAPs) and caspases
by: Cregan, I., et al.
Published: (2013)

Are children more vulnerable to mesothelioma than adults? A comparison of mesothelioma risk among children and adults exposed non-occupationally to blue asbestos at Wittenoom
by: Reid, Alison, et al.
Published: (2018)

Optimization of EDM parameters for micro/meso fabrication
by: Ali, Mohammad Yeakub, et al.
Published: (2006)